Dashboard
Manage Tickers

CELZ CREATIVE MEDICAL TECHNOLOGY...

Nasdaq creativemedicaltechnology.com


$ 3.82 $ 0.02 (0.53 %)    

Wednesday, 22-Oct-2025 15:25:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.30 $ -6.44 (-1.05 %)
DIA $ 465.76 $ -3.46 (-0.74 %)
SPY $ 667.06 $ -4.83 (-0.72 %)
TLT $ 92.08 $ 0.09 (0.1 %)
GLD $ 377.35 $ 4.48 (1.2 %)
$ 3.71
$ 3.90
$ 3.76 x 100
$ 3.90 x 500
$ 3.79 - $ 3.95
$ 1.69 - $ 6.90
48,794
na
9.57M
$ -38.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 03-14-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-22-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-17-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 04-06-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-20-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-21-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 02-13-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-19-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 04-14-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

creative-medical-technologies-will-be-issued-us-patent-number-12391925-tomorrow-titled-prevention-andor-treatment-of-type-1-diabetes-by-augmentation-of-myeloid-suppressor-cell-activity
Creative Medical Technologies will be issu...
08/18/2025 20:02:09

https://x.com/patentgrants/status/1957532080155562158?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

creative-medical-technology-receives-fda-fast-track-designation-for-celz-201-ddt-in-degenerative-disc-disease
Creative Medical Technology Receives FDA F...
08/13/2025 13:02:55

creative-medical-technology-holdings-receives-notice-from-us-patent-and-trademark-office-for-us-patent-application-titled-prevention-andor-treatment-of-type-1-diabetes-by-augmentation-of-myeloid-suppressor-cell-activity
Creative Medical Technology Holdings Recei...
07/17/2025 13:17:42

creative-medical-technology-announces-notice-of-allowance-from-uspto-for-patent-application-titled-treatment-of-heart-failure-andor-post-infarct-pathological-remodeling-by-ex-vivo-reprogrammed-immune-cells
Creative Medical Technology Announces Noti...
07/11/2025 12:03:58

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 17:05:47

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 12:09:22

us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus
US Stocks Likely To Open Lower A Day After...
07/10/2025 10:29:55

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

why-wk-kellogg-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why WK Kellogg Shares Are Trading Higher B...
07/10/2025 09:47:28

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 21:06:40

creative-medical-technology-has-received-a-notice-of-allowance-for-a-us-patent-titled-treatment-of-heart-failure-andor-post-infarct-pathological-remodeling-by-ex-vivo-reprogrammed-immune-cells
Creative Medical Technology Has Received A...
07/09/2025 19:55:49

https://patentcenter.uspto.gov/applications/17559970/ifw/docs

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/18/2025 17:06:11

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/10/2025 21:06:05

creative-medical-says-fda-cleared-expanded-dose-escalation-for-phase-12-trial-of-stemspine-using-allostem-for-chronic-lower-back-pain
Creative Medical Says FDA Cleared Expanded...
03/20/2025 11:52:34

creative-medical-technology-holdings-enters-agreements-with-certain-warrant-holders-for-the-exercise-of-warrants-37m-gross-proceeds
Creative Medical Technology Holdings Enter...
03/06/2025 13:23:06

creative-medical-technology-announces-ovastem-shows-85-hormonal-improvement-70-success-orphan-drug-designation-filed
Creative Medical Technology Announces OvaS...
02/20/2025 13:09:13

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a leading biotechnology innovator in regenerative medicine, enthusias...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/14/2025 21:05:48

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/14/2025 12:05:40

creative-medical-technology-holdings-announces-mid-term-follow-up-study-data-reporting-reduction-in-opioid-use-by-chronic-lower-back-pain-patients-undergoing-stemspine-procedure-using-allostem
Creative Medical Technology Holdings Annou...
02/14/2025 12:05:17

Notably, over 90% of patients reported no opioid use for pain management three years post-procedure, with an 80% persistent red...

creative-medical-technology-reports-one-year-results-for-allostem-type-2-diabetes-program
Creative Medical Technology Reports One-Ye...
02/11/2025 14:27:26

Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependency and stabilizing hemoglob...

creative-medical-technology-announces-an-expanded-agreement-with-greenstone-biosciences-to-leverage-artificial-intelligence-in-further-developing-its-human-induced-pluripotent-stem-cell-platform-for-diabetes-treatment
Creative Medical Technology Announces An E...
02/05/2025 13:27:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION